SkinHealth Systems (SKIN) Total Non-Current Liabilities (2020 - 2026)
SkinHealth Systems' (SKIN) quarterly Total Non-Current Liabilities came in at $428.7 million in Q2 2026, down 0.67% year-over-year from $431.6 million in Q2 2025, and up 3.14% quarter-over-quarter from $415.6 million in Q1 2026.
Analysis
SkinHealth Systems (SKIN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Total Non-Current Liabilities for 7 consecutive years, with $428.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 0.67% year-over-year to $428.7 million in Q2 2026; TTM through Jun 2026 was $428.7 million, a 0.67% decrease from a year earlier, with the FY2025 full-year figure at $436.3 million, down 30.91% from the prior year.
- Total Non-Current Liabilities was $428.7 million for Q2 2026 at SkinHealth Systems, up from $415.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $876.0 million in Q3 2023 and troughed at $415.6 million in Q1 2026.
- A 5-year average of $675.4 million and a median of $708.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities surged 4722.81% in 2022 and plunged 33.6% in 2026, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $820.6 million in 2022, then advanced by 5.56% to $866.2 million in 2023, then fell by 27.09% to $631.6 million in 2024, then plunged by 30.91% to $436.3 million in 2025, then fell by 1.75% to $428.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $428.7 million (Q2 2026), $415.6 million (Q1 2026), and $436.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.61 Bn | 179.00 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 126.43 Bn | 121.22 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 119.26 Bn | 110.45 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 106.19 Bn | 102.71 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 67.54 Bn | 67.00 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 50.12 Bn | 45.87 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 34.19 Bn | 32.73 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 31.88 Bn | 29.94 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.21 Bn | 20.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | SkinHealth Systems | 92.21 Mn | -113.87 Mn | 49.34 Mn | 428.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 428.69 Mn |
| Mar 31, 2026 | 415.62 Mn |
| Dec 31, 2025 | 436.34 Mn |
| Sep 30, 2025 | 436.09 Mn |
| Jun 30, 2025 | 431.57 Mn |
| Mar 31, 2025 | 625.96 Mn |
| Dec 31, 2024 | 631.56 Mn |
| Sep 30, 2024 | 639.13 Mn |
| Jun 30, 2024 | 640.80 Mn |
| Mar 31, 2024 | 776.43 Mn |
| Dec 31, 2023 | 866.17 Mn |
| Sep 30, 2023 | 876.01 Mn |
| Jun 30, 2023 | 832.67 Mn |
| Mar 31, 2023 | 822.74 Mn |
| Dec 31, 2022 | 820.56 Mn |
| Sep 30, 2022 | 824.59 Mn |
| Jun 30, 2022 | 836.05 Mn |
| Mar 31, 2022 | 815.71 Mn |
| Dec 31, 2021 | 822.69 Mn |
| Sep 30, 2021 | 782.76 Mn |